Table 1:
Participant Population
| Population | Solithromycin (n=70) |
Comparator (n=24) |
|---|---|---|
| Age in years, mean (SD) | 9.5 (4.7) | 9.7 (5.0) |
| Female sex, n (%) | 30 (42.9) | 11 (45.8) |
| Race, n (%) | ||
| Black or African American | 11 (15.7) | 2 (8.3) |
| White | 47 (67.1) | 16 (66.7) |
| Asian | 12 (17.1) | 4 (16.7) |
| Other | 0 (0) | 2 (8.3) |
| Hispanic/Latino ethnicity, n (%) | 2 (2.9) | 2 (8.3) |
| Medical history at enrollment | ||
| Asthma | 12 (17.1) | 3 (12.5) |
| Allergic disease | 5 (7.1) | 2 (8.3) |
| Tracheomalacia | 1 (1.4) | 0 (0) |
| ADHD | 0 (0) | 0 (0) |
| Restrictive Lung Disease | 0 (0) | 1 (4.2) |
| GERD | 3 (4.3) | 0 (0) |
| Region of enrollment, n (%) | ||
| Bulgaria | 21 (30) | 6 (25) |
| Hungary | 19 (27.1) | 4 (16.7) |
| Philippines | 12 (17.1) | 4 (16.7) |
| Spain | 0 (0) | 1 (4.2) |
| United States | 18 (25.7) | 9 (37.5) |
SD - standard deviation, ADHD – attention deficit/hyperactivity disorder, GERD – gastroesophageal reflux disease